mGWAS: next generation genetic prediction in kidney disease
- PMID: 32231316
- PMCID: PMC7261371
- DOI: 10.1038/s41581-020-0270-0
mGWAS: next generation genetic prediction in kidney disease
Abstract
A recent metabolite genome-wide association study (mGWAS) investigated the relationship between genetic factors and the urine metabolome in kidney disease. The findings demonstrate that mGWAS hold promise for identifying novel genetic factors involved in adsorption, distribution, metabolism and excretion of metabolites and pharmaceuticals, as well as biomarkers for disease progression.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Comment on
-
Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.Nat Genet. 2020 Feb;52(2):167-176. doi: 10.1038/s41588-019-0567-8. Epub 2020 Jan 20. Nat Genet. 2020. PMID: 31959995 Free PMC article.
References
-
- Sandholm N & Groop PH Genetic basis of diabetic kidney disease and other diabetic complications. Curr. Opin. Genet. Dev 50, 17–24 (2018). - PubMed
-
- Köttgen A, Raffler J, Sekula P & Kastenmüller G Genome-wide association studies of metabolite concentrations (mGWAS): relevance for nephrology. Semin. Nephrol 38, 151–174 (2018). - PubMed
-
- Suhre K, Raffler J & Kastenmüller G Biochemical insights from population studies with genetics and metabolomics. Arch. Biochem. Biophys 589, 168–176 (2016). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
